Company Search:
Advanced Search
Sponsored Links
Theravance Biopharma Inc Company Snapshot
Theravance Biopharma Inc operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Theravance Biopharma Inc with three other companies in this sector in UNITED STATES : Flexion Therapeutics Inc (2019 sales of $72.96 million of which 100% was Pharmaceutical), Vivus, Inc. ($69.76 million of which 100% was Development and commercialization of nov), and Aerie Pharmaceuticals Inc ($69.89 million of which 100% was development and commercialization of pha).

Sales Analysis. During the year ended December of 2019, sales at Theravance Biopharma Inc were $73.41 million. This is an increase of 21.6% versus 2018, when the company's sales were $60.37 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Theravance Biopharma Inc
  Stock Performance Chart for Theravance Biopharma Inc
  Stock Data: Recent Stock Performance:
  Current Price (9/18/2020): 17.82
(Figures in U.S. Dollars)
1 Week 5.6%   13 Weeks -3.4%  
4 Weeks -18.5%   52 Weeks -21.1%  
Theravance Biopharma Inc Key Data:
  Ticker: TBPH Country: Cayman Islands
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 73,414,000
(Year Ending Jan 2020).
Employees: 316
  Currency: U.S. Dollars Market Cap: 1,131,837,300
  Fiscal Yr Ends: December Shares Outstanding: 63,515,000
  Share Type: Common Closely Held Shares: 13,206,682
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.